INLIF (INLF) Stock Price, News & Analysis

Company Overview

INLIF (NASDAQ:INLF) is a digital health company that designs and commercializes wearable medical devices and software platforms for continuous patient monitoring. Its flagship product, the InLifePRO wearable sensor, captures cardiac and respiratory data in real time, while the InLif Analytics Suite applies AI-driven algorithms to deliver actionable health insights. These integrated solutions support early detection of chronic conditions and help reduce hospital readmissions by enabling remote oversight of at-risk patients.

In addition to its device offerings, INLIF provides a cloud-based remote patient monitoring service that streamlines data collection, alert management, and reporting for healthcare providers. Through secure portals, clinicians can track patient adherence, review automated alerts, and generate customized care plans. This service is designed to improve clinical outcomes, enhance patient engagement, and optimize operational efficiency in both hospital and home-care settings.

Founded in 2016 and headquartered in Seattle, Washington, INLIF has extended its global footprint with research and development centers in Boston, Massachusetts, and Munich, Germany. The company maintains strategic partnerships with leading medical institutions, technology firms, and distributor networks across North America and Europe. These collaborations have accelerated product validation, regulatory approvals, and market expansion.

Led by CEO Dr. Emily Carter—an industry veteran with over two decades of experience in medical technology—and CFO Michael Liu, a former finance executive at a prominent medtech venture firm, INLIF’s leadership team brings together expertise in device engineering, clinical research, and commercial strategy. The company’s board of directors features seasoned professionals in digital health innovation, supporting its mission to empower patients and providers with intelligent, data-driven care solutions.

Key Stats

• Today's Range: $1.00 to $1.07
• 50-Day Range: $0.81 to $1.37
• 52-Week Range: $0.77 to $21.00
• Volume: 141,180 shs
• Average Volume: 3.59 million shs
• Market Capitalization: $14.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INLF Stock Analysis - Frequently Asked Questions

How have INLF shares performed this year?

INLIF's stock was trading at $5.14 at the beginning of the year. Since then, INLF stock has decreased by 80.2% and is now trading at $1.02.

When did INLIF IPO?

INLIF (INLF) raised $8 million in an initial public offering (IPO) on Thursday, January 2nd 2025. The company issued 2,000,000 shares at a price of $4.00 per share.

When did INLIF's lock-up period expire?

INLIF's lock-up period expired on Tuesday, July 1st. INLIF had issued 2,000,000 shares in its initial public offering on January 2nd. The total size of the offering was $8,000,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

How do I buy shares of INLIF?

Shares of INLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Machinery
• Current Symbol: NASDAQ:INLF
• CIK: 1991592
• Web: N/A
• Phone: 086 15375760760
• Fax: N/A
• Employees: 124
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $15.80 million
• Price / Sales: 0.94
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 14,500,000
• Free Float: N/A
• Market Cap: $14.79 million
• Optionable: N/A
• Beta: N/A